Devices › Device types
FDA product code LQC · class 2 · Gastroenterology, Urology
Lithotriptor, biliary mechanical: medical device reports filed with FDA
2,901 reports carry this product code, 1996–2026; 8 brands with a page.
- 2,901
- reports with this product code
- 0% of all MAUDE reports
- 193
- reports, 12 months to August 2026
- 132 in the 12 months before
- 75.9%
- classified as malfunction
- 62.3% across all reports
- 0.4%
- classified as death, as reported
- 0.9% across all reports
Product code LQC is FDA's classification for "Lithotriptor, biliary mechanical" (gastroenterology, Urology panel), a class 2 device. 2,901 medical device reports carry this product code, 0% of the MAUDE database, from May 1996 to August 2026.
193 reports arrived in the 12 months to August 2026, up 46% from 132 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (75.9%), injury (22.9%) and other (0.6%). 8 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Trapezoid RX | 1,503 | 132 | 0.3% | 80.7% |
| Single Use Mechanical Lithotriptor V | 553 | 57 | 0.5% | 73.6% |
| Trapezoid Rx Lithotripter Compatible Basket | 212 | 0 | 0.5% | 69.3% |
| Trapezoid Rx Lithotripter Compatible Basket Models 1086 1087 1088 | 181 | 0 | 0% | 84% |
| Karl Storz | 2 | 0 | 2.1% | 24.6% |
| Flexiva | 1 | 0 | 0% | 93.4% |
| Single Use 3-Lumen Sphincterotome V | 1 | 256 | 0.2% | 95.7% |
| Zero Tip | 1 | 44 | 0% | 62.3% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Boston Scientific - Spencer | 712 | 24.5% |
| Aomori Olympus | 388 | 13.4% |
| Olympus Medical Systems | 64 | 2.2% |
| Olympus Medical System | 56 | 1.9% |
| Olympus Optical | 29 | 1% |
| Wilson-Cook Medical | 2 | 0.1% |
| Boston Scientific - Costa Rica | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Breakthe device broke | 1,252 | 43.2% |
| Material deformation | 371 | 12.8% |
| Separation failure | 224 | 7.7% |
| Detachment of device or device componentpart of the device came off | 201 | 6.9% |
| Material split, cut or torn | 186 | 6.4% |
| Difficult to removethe device was hard to remove | 182 | 6.3% |
| Detachment of device component | 139 | 4.8% |
| Difficult to open or close | 139 | 4.8% |
| Other (for use when an appropriate device code cannot be identified) | 55 | 1.9% |
| Premature activation | 50 | 1.7% |
| Replace | 48 | 1.7% |
| Component(s), broken | 42 | 1.4% |
| Torn material | 39 | 1.3% |
| Device issuea problem with the device | 37 | 1.3% |
| Tip breakage | 37 | 1.3% |
| Wire(s), breakage of | 34 | 1.2% |
| Source, detachment from | 33 | 1.1% |
| Device, or device fragments remain in patient | 30 | 1% |
| Device handling problem | 28 | 1% |
| Entrapment of device | 27 | 0.9% |
Questions about lithotriptor, biliary mechanical reports
What is product code LQC?
FDA's classification code for "Lithotriptor, biliary mechanical", class 2, reviewed by the gastroenterology, Urology panel. Every device report carries the product code of the device involved.
How many reports carry this code?
2,901 reports through August 2026, 193 of them in the latest 12 months.
Which brands appear most often?
Trapezoid RX (1,503), Single Use Mechanical Lithotriptor V (553), Trapezoid Rx Lithotripter Compatible Basket (212), Trapezoid Rx Lithotripter Compatible Basket Models 1086 1087 1088 (181) and Karl Storz (2). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.